| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 14/01/2011 | 12:01 | Edgar (US Regulatory) | Post-Effective Amendment to Registration Statement (POS AM) | NASDAQ:CYPB | Cypress Bioscience, Inc. (MM) |
| 14/01/2011 | 12:01 | Edgar (US Regulatory) | Termination of Registration of a Class of Security under Section 12(g) (15-12G) | NASDAQ:CYPB | Cypress Bioscience, Inc. (MM) |
| 14/01/2011 | 12:01 | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NASDAQ:CYPB | Cypress Bioscience, Inc. (MM) |
| 06/01/2011 | 14:00 | PR Newswire (US) | Ramius and Royalty Pharma Announce Successful Conclusion of Cypress Bioscience Tender Offer | NASDAQ:CYPB | Cypress Bioscience, Inc. (MM) |
| 04/01/2011 | 23:06 | Edgar (US Regulatory) | Amended tender offer statement by Third Party (SC TO-T/A) | NASDAQ:CYPB | Cypress Bioscience, Inc. (MM) |
| 04/01/2011 | 14:30 | Marketwired | FTC Grants Early Termination of Waiting Period Under Hart-Scott-Rodino Act | NASDAQ:CYPB | Cypress Bioscience, Inc. (MM) |
| 04/01/2011 | 12:03 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (SC 14D9/A) | NASDAQ:CYPB | Cypress Bioscience, Inc. (MM) |
| 29/12/2010 | 19:37 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CYPB | Cypress Bioscience, Inc. (MM) |
| 23/12/2010 | 22:21 | Edgar (US Regulatory) | Statement of Beneficial Ownership (SC 13D) | NASDAQ:CYPB | Cypress Bioscience, Inc. (MM) |
| 22/12/2010 | 22:08 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:CYPB | Cypress Bioscience, Inc. (MM) |
| 22/12/2010 | 12:06 | Edgar (US Regulatory) | Amended Securities Registration (section 12(b)) (8-A12B/A) | NASDAQ:CYPB | Cypress Bioscience, Inc. (MM) |
| 21/12/2010 | 14:45 | PR Newswire (US) | Ramius and Royalty Pharma Extend Tender Offer Until January 5, 2011 Pursuant to Definitive Merger Agreement | NASDAQ:CYPB | Cypress Bioscience, Inc. (MM) |
| 20/12/2010 | 23:20 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:CYPB | Cypress Bioscience, Inc. (MM) |
| 20/12/2010 | 18:26 | Business Wire | Cypress Bioscience, Inc. Shareholder Investigation by Briscoe Law Firm Concerning Acquisition by Ramius V&O Acquisition, LLC | NASDAQ:CYPB | Cypress Bioscience, Inc. (MM) |
| 17/12/2010 | 19:59 | Business Wire | The Law Office of Abe Shainberg Launches an Investigation into the Possible Breaches of Fiduciary Duty by the Board of Cypres... | NASDAQ:CYPB | Cypress Bioscience, Inc. (MM) |
| 17/12/2010 | 01:30 | Business Wire | Law Offices of Howard G. Smith Announces Investigation On Behalf of Shareholders of Cypress Bioscience, Inc., in Connection w... | NASDAQ:CYPB | Cypress Bioscience, Inc. (MM) |
| 16/12/2010 | 17:26 | Business Wire | The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into the Possible Breaches of Fiduciary Duty by the Board of ... | NASDAQ:CYPB | Cypress Bioscience, Inc. (MM) |
| 15/12/2010 | 20:49 | Business Wire | The Law Firm of Weiss & Lurie Investigates the Acquisition of Cypress Bioscience, Inc. by Ramius V&O Acquisition LLC & Royalt... | NASDAQ:CYPB | Cypress Bioscience, Inc. (MM) |
| 15/12/2010 | 14:00 | Business Wire | Cypress Bioscience Agrees To Be Acquired by Ramius LLC and Royalty Pharma for $6.50 Per Share in Cash | NASDAQ:CYPB | Cypress Bioscience, Inc. (MM) |
| 14/12/2010 | 16:51 | PR Newswire (US) | Cypress Board Rejects Ramius' $6.00 All-Cash Offer | NASDAQ:CYPB | Cypress Bioscience, Inc. (MM) |
| 10/12/2010 | 17:47 | Business Wire | Cypress Bioscience Board of Directors Confirms Receipt of Revised Ramius LLC Offer in Connection with Strategic Review Process | NASDAQ:CYPB | Cypress Bioscience, Inc. (MM) |
| 10/12/2010 | 15:29 | PR Newswire (US) | Ramius Offers to Enter Into Immediate and Exclusive Negotiations to Acquire Cypress Bioscience for $5.50 Per Share | NASDAQ:CYPB | Cypress Bioscience, Inc. (MM) |
| 09/11/2010 | 14:01 | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:CYPB | Cypress Bioscience, Inc. (MM) |
| 09/11/2010 | 12:30 | Marketwired | Cypress Bioscience Announces Third Quarter 2010 Financial Results | NASDAQ:CYPB | Cypress Bioscience, Inc. (MM) |
| 03/11/2010 | 11:30 | Marketwired | Cypress Bioscience, Inc. to Present at Oppenheimer 21st Annual Healthcare Conference | NASDAQ:CYPB | Cypress Bioscience, Inc. (MM) |
| 02/11/2010 | 22:45 | PR Newswire (US) | Ramius Extends Tender Offer to Acquire Cypress | NASDAQ:CYPB | Cypress Bioscience, Inc. (MM) |
| 11/10/2010 | 19:23 | Dow Jones News | UPDATE: FDA Wants More Data For Jazz Pharma Fibromyalgia Drug | NASDAQ:CYPB | Cypress Bioscience, Inc. (MM) |
| 08/10/2010 | 23:05 | Marketwired | Cypress Bioscience Announces Agreement to Sell Diagnostic Business to Exagen Diagnostics | NASDAQ:CYPB | Cypress Bioscience, Inc. (MM) |
| 30/09/2010 | 19:37 | PR Newswire (US) | Ramius Sends Letter to Independent Members of the Cypress Board | NASDAQ:CYPB | Cypress Bioscience, Inc. (MM) |
| 28/09/2010 | 14:21 | Marketwired | Cypress Bioscience Board of Directors Unanimously Rejects Ramius' Unsolicited Tender Offer | NASDAQ:CYPB | Cypress Bioscience, Inc. (MM) |